Figure 5.
The role of EVs as endogenous carriers in treating A) head and neck squamous cell carcinoma, B) nasopharyngeal carcinoma, and C) chronic myeloid leukemia.
The role of EVs as endogenous carriers in treating A) head and neck squamous cell carcinoma, B) nasopharyngeal carcinoma, and C) chronic myeloid leukemia.